Infections, Complications, and Management of Liver Transplantation

A special issue of Transplantology (ISSN 2673-3943). This special issue belongs to the section "Solid Organ Transplantation".

Deadline for manuscript submissions: closed (31 December 2021) | Viewed by 3907

Special Issue Editor


E-Mail Website
Guest Editor
Department of Pediatric Surgery, Kanazawa Medical University, Ishikawa, Japan
Interests: pediatric liver transplantation; management of complications after liver transplantation

Special Issue Information

Dear Colleagues,

Since the development of pre-and post-liver transplant management, the outcomes of liver transplantation have been improving. However, infection after organ transplantation is still one of the most important complicated issues of immunosuppressants. In particular, fungal infection after not liver, but other organ transplantation, has been correlated with negative outcomes, as well as morbidity and mortality, after transplantation. Moreover, viral infections such as Epstein Bar virus, which has a well-known as a risk of lymphoproliferative disorder including malignant lymphoma, and others, should be monitored and managed, even in long term follow-up liver transplant recipients, so as to improve the outcomes of liver transplantation.

In the present Special Issue, we aim to collect a number of reviews and original articles that highlight the innovative monitoring and management of infections in patients that have undergone liver transplantation, including innovative monitoring and management of rejection and the maintenance of immunosuppressants in the recent era. Not only fungal infection but also bacterial and viral infections after liver transplantation are topics welcome for submission.

In summary, this Special Issue will help readers to get an up-to-date and authoritative view of the management of infection after liver transplantation in order to improve the outcome of liver transplant recipients.

Prof. Dr. Hideaki Okajima
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Transplantology is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Liver transplantation
  • Infections after liver transplantation
  • Monitoring of infection
  • Management of infection
  • Monitoring of rejection
  • Management of rejection

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

12 pages, 232 KiB  
Review
The Revolution in Indication for Liver Transplantation: Will Liver Metastatic Disease Overcome the End-Stage Liver Disease in the Next Future?
by Tommaso Maria Manzia, Alessandro Parente, Roberta Angelico, Carlo Gazia and Giuseppe Tisone
Transplantology 2020, 1(2), 111-122; https://0-doi-org.brum.beds.ac.uk/10.3390/transplantology1020011 - 02 Dec 2020
Cited by 2 | Viewed by 3503
Abstract
Indications for liver transplantation (LT) have constantly been evolving during the last few decades due to a better understanding of liver diseases and innovative therapies. Likewise, also the underlying causes of liver disease have changed. In the setting of transplant oncology, recent developments [...] Read more.
Indications for liver transplantation (LT) have constantly been evolving during the last few decades due to a better understanding of liver diseases and innovative therapies. Likewise, also the underlying causes of liver disease have changed. In the setting of transplant oncology, recent developments have pushed the boundaries of oncological indications for LT outside hepatocellular carcinoma (HCC), especially for secondary liver tumors, such as neuroendocrine and colorectal cancer. In the next years, as more evidence emerges, LT could become the standard treatment for well-selected metastatic liver tumors. In this manuscript, we review and summarize the available evidence for LT in liver tumors beyond HCC with a focus on metastatic liver malignancies, highlighting the importance of these new concepts for future implications. Full article
(This article belongs to the Special Issue Infections, Complications, and Management of Liver Transplantation)
Back to TopTop